Latest Production News

Resonance Health reports record $14.9M cash receipts over 12 months and completes cost-cutting measures while advancing two major pharma clinical trials on schedule.

Fitzroy River Corporation reported steady royalty income for the year ending March 2025, alongside key strategic agreements and a planned capital return, navigating a volatile global energy landscape.

Flagship Minerals’ metallurgical review of the Pantanillo Gold Project highlights strong gold recoveries from oxide mineralisation and suggests a pathway to low capital and operating costs through heap and dump leach processing.

Beach Energy reported steady production and strong financials in Q3 FY25 despite flood disruptions in the Cooper Basin, with key projects advancing and liquidity improving.

Nickel Industries delivered a robust US$97.3 million Adjusted EBITDA in Q1 2025 despite production challenges and a declining nickel price. Key milestones include approval to nearly double Hengjaya Mine’s ore sales quota and a strategic deferral of substantial ENC acquisition payments.

Harmoney Corp upgrades its FY25 cash NPAT guidance to $5.5 million, driven by strong loan book growth and improved margins, while announcing a strategic 5% on-market share buy-back.

Advance Metals Limited reports breakthrough drilling results at its Myrtleford Gold Project and advances strategic acquisitions in Mexico, positioning itself for significant growth in precious metals exploration.

Titan Minerals reports significant drilling progress and metallurgical breakthroughs at its Dynasty Gold Project, while JV partner Hanrine accelerates Linderos Copper drilling. The company strengthens its balance sheet with a $25.7 million capital raise and clears debt.

Delta Lithium has announced a substantial 46% increase in the gold resource at its Mt Ida Project, now exceeding 1.1 million ounces, alongside plans to spin off its gold assets into a new ASX-listed entity, Ballard Mining.

Connected Minerals Ltd has advanced its uranium exploration in Namibia with impressive trench sampling results and commenced a significant drilling campaign, while also initiating base metal exploration in Western Australia.

Medical Developments International reported a robust Q3 FY25 with $8.9 million revenue and $1.7 million operating cashflow, driven by strong Penthrox demand and pricing. New distribution agreements in France and Switzerland position the company for further European expansion.

Syrah Resources reports a strategic pause at its Balama graphite mine while advancing production at its Vidalia AAM facility, navigating evolving US trade policies and strong EV-driven demand. The company’s integrated ex-China supply chain and ESG credentials position it for growth despite near-term operational headwinds.